期刊文献+

原发性肉碱缺乏症性心肌病患儿基因突变及家系分析 被引量:10

Genetics and pedigree analysis of primary carnitine deficiency cardiomyopathy in 6 cases
原文传递
导出
摘要 目的 探讨以心肌病为唯一临床症状的原发性肉碱缺乏症患儿SLC22A5基因突变情况.方法 2012年12月至2013年10月在广东省心血管病研究所对6例原发性肉碱缺乏症患儿及其父母进行基因检测,6例患儿中男4例、女2例,年龄6个月~15岁.从患儿及其父母静脉全血中提取DNA,采用高通量测序法直接测序确定其突变位点及类型;采用Sanger法验证患儿高通量测序的结果并测定患儿父母的相应序列,明确突变的遗传来源.对检测到的错义突变采用SIFT和PolyPhen进行突变位点功能预测.结果 6例患儿均检测到SLC22A5基因突变,共检出3个突变位点,包括2种无义突变R254X和R289X,1种错义突变C113Y,4例为复合突变,2例为纯合突变,其中R254X突变率最高.患儿父母均为相应基因的杂合突变.结论 R254X、R289X和C113Y为原发性肉碱缺乏症的可疑致病突变. Objective To investigate the mutation and background of SLC22A5 in 6 patients with primary carnitine deficiency (PCD) who only presented as cardiomyopathy.Method Genomic DNA were abstracted from the blood of the patients and their parents.Using high-throughput sequencing to determine the mutation site.Using Sanger method to confirm the mutated alleles in PCD patients and detect the corresponding sequences in their patients.Using SIFT and PolyPhen to predict the function of protein for detected missense mutations.Result Three different mutations were identified,including 2 nonsense mutations (R254X and R289X),1 missense mutation (C113Y),R254X was the most frequently seen mutation.Four patients had compound heterozygous mutations and 2 patients had homozygous mutations.Their parents were found to have heterozygous mutations in corresponding alleles.Conclusion R254X,R289X and C113Y might be associated with primary carnitine deficiency.
机构地区 [
出处 《中华儿科杂志》 CAS CSCD 北大核心 2014年第7期544-547,共4页 Chinese Journal of Pediatrics
基金 广东省医学科研基金(B2012014)
关键词 肉碱 心肌疾病 基因型 杂合子 Carnitine Cardiomyopathies Genotype Heterozygote
  • 相关文献

参考文献12

  • 1Amat DS, Taylor MR, Mestroni L, et al. Cardiomyopathy and carnitine deficiency[ J]. Mol Genet Metab, 2008, 94 : 162-166.
  • 2Li FY, E1-Hattab AW, Bawle EV, et al. Molecular spectrum of SLC22A5 (OCTN2) gene mutations detected in 143 subjects evaluated for systemic carnitine deficiency [ J ]. Hum Murat,2010, 31 :E1632-E1651.
  • 3Lee NC, Tang NL, Chien YH, et al. Diagnoses of newborns and mothers with earnitine uptake defects through newborn screening [J]. Mol Genet Metab, 2010, 100:46-50.
  • 4Yamak A, Bitar F, Karam P, et al. Exclusive cardiac dysfunction in familial primary carnitine deficiency cases: a genotype- phenotype correlation[J]. Clin Genet, 2007, 72:59-62.
  • 5Tang NL, Hwu WL, Chan RT, et al. A founder mutation (R254X) of SLC22A5 ( OCTN2 ) in Chinese primary carnitine deficiency patients[ J]. Hum Mutat, 2002, 20:232.
  • 6Lamhonwah AM, Onizuka R, Olpin SE, et al. OCTN2 mutation (R254X) found in Saudi Arabian kindred: recurrent mutation or ancient founder mutation? [ J]. J Inherit Metab Dis, 2004, 27: 473-476.
  • 7Amat di San Filippo C, Pasquali M, Longo N. Pharmacological rescue of carnitine transport in primary carnitine deficiency [ J ]. Hum Mutat, 2006, 27:513-523.
  • 8Spiekerkoetter U, Huener G, Baykal T, et al. Silent and symptomatic primary carnitine deficiency within the same family due to identical mutations in the organic cation/earnitine transporter OCTN2[ J]. J Inherit Metab Dis, 2003, 26:613-615.
  • 9Wang Y, Kelly MA, Cowan TM, et al. A missense mutation in the OCTN2 gene associaled with residual carnitine transport activity[ J]. Hum Murat, 2000, 15:238-245.
  • 10Wang Y, Taroni F, Garavaglia B, et al. Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency: lack of genotype-phenotype correlation [ J ]. Hum Murat, 2000, 16:401-407.

同被引文献53

引证文献10

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部